×
戻る Agendas
REAL WORLD EVIDENCE FOR MEDICINES ADAPTIVE PATHWAYS TO PATIENTS (MAPPS)
Session Chair(s)
Chris Chinn, MSC
Real World Evidence for Market Access
Sanofi, United Kingdom
Optimising Patient-Centricity Through Multilingual Social Intelligence
Learning Objective : - Recognize the significance of multilingual social analytics as a tool to understanding the patient journey and increase patient-centricity - Appraise differences in approach to disease states, diagnosis and treatment across different lingusitic and cultural groups - Recognize the importance of social analytics as an indispensable tool for global pharma companies in the 21st Century
Speaker(s)
Harnessing Real World Evidence
Jonathan Cave
University of Warwick, United Kingdom
Senior Research Analyst, RAND Europe; Senior Tutor, Economics
Optimising Patient-Centricity Through Multilingual Social Intelligence
Liesl Leary
SDL plc, United States
Director, Social Intelligence and Solutions
Opt-in, Opt-out, & Patient Led Databases. Better Patient Outcomes, Faster and Cheaper
Duane Schulthess, MBA
Vital Transformation LLC, United States
Chief Executive Officer